Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02179944 · ClinicalTrials.gov registry record
Human Chorionic Gonadotropin (hCG) Trend After Medication Abortion
A clinical trial, sponsored by Planned Parenthood League of Massachusetts.
- Completed
- Registry status
- 66
- Enrollment target
NCT02179944: Completed study, sponsored by Planned Parenthood League of Massachusetts.
NCT02179944 is a clinical trial that has completed, run by Planned Parenthood League of Massachusetts. The registered enrollment target is 66 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02179944 has completed, sponsored by Planned Parenthood League of Massachusetts.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
This project will be a prospective physiologic study. We will closely follow 60 medication abortion patients with serial repeat serum hCG and urine semi-quantitative hCG testing. We plan to recruit patients from two gestational age strata: ≤ 49 days and \> 49 days. Study Objectives: 1. To create a nomogram describing the change in serum hCG values in the first five days immediately following medication abortion with mifepristone and misoprostol. Specifically, we will describe the percent serum hCG decline from Day 1 (day of mifepristone) to Day 3 (day after misoprostol), from Day 1 to Day 5, and from Day 1 to Day 7-10. 2. To explore whether there is a significant difference in the rate of hCG decline based on initial gestational age determined by ultrasound and initial serum hCG. 3. To describe the correlation between semi-quantitative urine hCG test results and serum hCG values to determine how soon after initiating medication abortion the urine test can detect completed abortion. We hypothesize that among successful medication abortions, there will be a predictable trend with at least a 50% drop by Day 3 and 80% drop by Day 5.
Primary Outcome
blood sample collection for hCG testing on Day 3, Day 5 and Day 7-10 (Day 1 is day of mifepristone administration)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-03 |
What the finished NCT02179944 record still lists
NCT02179944 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 66 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02179944 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02179944 about?
NCT02179944 is a clinical study titled "Human Chorionic Gonadotropin (hCG) Trend After Medication Abortion". This project will be a prospective physiologic study. We will closely follow 60 medication abortion patients with serial repeat serum hCG and urine semi-quantitative hCG testing. We plan to recruit patients from two gestational age strata: ≤ 49 days and \> 49 days. Study Objectives: 1. To create a...
What is the current status of trial NCT02179944?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2014-07. Estimated completion is 2015-03.
Who is sponsoring clinical trial NCT02179944?
This trial is sponsored by Planned Parenthood League of Massachusetts, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia